Patriots Partner With vineyard vines

The Patriots partner with vineyard vines.  Honoring their New England roots and love of football, vineyard vines emerges as the official style of the New England Patriots and Gillette Stadium.  Exclusive products are offered through the 2018 and 2019 seasons.  The collection comprises clothing and accessories for men, women, and children.  Also on hand at the new vineyard vines pop-up at 229 Patriot Place, next to Gillette Stadium.
   
Ian Murray of vineyard vines said: 'We are proud to partner with the Patriots and their outstanding organization to be the Official Style of the Patriots and Gillette Stadium.  The Krafts are true entrepreneurs and as entrepreneurs ourselves we are inspired by the organization they've built.  This partnership is also a great complement to both our role as official style of the Boston Red Sox and within the NFL our licensed product collaborations with all teams.' 
   
Shep Murray of vineyard vines added: 'As a proud New England brand, we couldn't be happier to partner with the beloved team, furthering our involvement in Boston, a winning and vibrant city that we love.  We are thrilled to be able to work with a team in a deeper way and share our love of the sport through this partnership.'
   
Murray Kohl of Kraft Sports + Entertainment said: 'We are thrilled to partner with a brand that shares our deep New England roots and entrepreneurial spirit.  For the past 20 years, vineyard vines has reminded us that Every day should feel this good in iconic New England-styled apparel and now our fans can enjoy looking this good, too.'
   
Exclusive to Gillette Stadium, vineyard vines will have digital LED signage within the stadium bowl. Kicking off in 2019, product will be available in all kiosks in premium seating areas of the stadium.

Comments

Post a Comment

Popular posts from this blog

Compass Buys Marucci

Compass buys Marucci.     Compass Diversified Holdings buys Marucci Sports for $200 million.     Marucci Sports was founded in 2009 by Kurt Ainsworth, a retired pitcher for the San Francisco Giants and Baltimore Orioles, Joe Lawrence, a former second baseman for the Toronto Blue Jays, and Reed Dickens, a former White House Assistant Press Secretary under George W. Bush.     Marucci ’s first buy was Marucci Bat Company, launched out of a backyard shed in 2004. Ainsworth then led the buyout of an Amish-run Pennsylvania wood mill in 2008. This solidified Marucci's superior wood supply, and it still supplies all Marucci's wood today. In 2017 Marucci bought Victus , a baseball equipment maker known for its edgy designs and big attitude.     With vertically cohesive wood bat production, a global supplier group, and a client base of MVPs and World Series winners, Marucci and Victus are the top two bats among Big League players. Their product range now includes wood
Read more

Pepsi Buys Rockstar

Pepsi buys Rockstar .     P epsiCo buys Rockstar Energy Beverages for $3.85 billion.     Founded in 2001, Rockstar is drinks designed for people leading an active lifestyle. Available in 20 flavors at convenience and grocery stores in 30 countries. Distributed by PepsiCo in North America since 2009. Supporting the Rockstar lifestyle across the globe through action sports, motorsports, and live music. Pepsi's energy portfolio also includes Kickstart , GameFuel, and Amp Energy.     The deal reflects the shift from reliance on sales of sugary, fizzy drinks toward options ranging from tea and coffee to still and sparkling water varieties, which appeal to health-conscious and younger consumers. Neither PepsiCo nor Coca-Cola owns a major brand in the energy drinks category, which is forecast to grow to more than $80 billion over the next five years and is now dominated by Red Bull.     2 00 countries and territories around the world enjoy PepsiCo products a billion times a
Read more

Gilead Buys Forty Seven

Gilead buys Forty Seven.     Gilead Sciences buys Forty Seven for $4.9 billion.     Forty Seven is a clinical-stage immuno-oncology firm developing therapies targeting cancer immune evasion pathways and specific cell targeting approaches based on tech licensed from Stanford. Forty Seven’s lead program, magrolimab , is a monoclonal antibody against the CD47 receptor, a ‘don’t eat me’ signal that cancer cells commandeer to avoid being ingested by macrophages. Evaluated ant ibodies are in many clinical studies of patients with myelodysplastic syndrome, acute myeloid leukemia, non-Hodgkin lymphoma, and solid tumors. These assets complement the cell therapy franchise Gilead added with its 2017 buy of Kite Pharma .     Beyond magrolimab , Forty Seven is fixing to advance two more compounds into clinical testing. Developing FSI-174, an anti-cKIT antibody, in combination with magrolimab creates a novel, all-antibody conditioning regimen to address the limitations of current st
Read more